B H E Jansen

Years Active: 2018-2020
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

B H E Jansen, Yves J L Bodar, G J C Zwezerijnen, D Meijer, J P van der Voorn, J A Nieuwenhuijzen, M Wondergem, T A Roeleveld, R Boellaard, O S Hoekstra, R J A van Moorselaar, D E Oprea-Lager, A N Vis
Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial. European journal of nuclear medicine and molecular imaging 48 (2) (2020)
M Wondergem, B H E Jansen, F M van der Zant, T M van der Sluis, R J J Knol, L W M van Kalmthout, O S Hoekstra, R J A van Moorselaar, D E Oprea-Lager, A N Vis
Early lesion detection with 18F-DCFPyL PET/CT in 248 patients with biochemically recurrent prostate cancer. European journal of nuclear medicine and molecular imaging 46 (9) (2019)
B H E Jansen, G W Disselhorst, Tim Schutte, B Jansen, Robert Rissmann, M C Richir, C J P W Keijsers, F H M Vanmolkot, A Maassen van den Brink, C Kramers, A M Vondeling, G J H Dumont, I de Waard-Siebinga, M A Van Agtmael, J Tichelaar
Essential diseases in prescribing: A national Delphi study towards a core curriculum in pharmacotherapy education. British journal of clinical pharmacology 84 (11) (2018)

B H E Jansen.css-eqlu8i{font-size:small;padding-left:4px;}